MENG, Raymond D.,KELLEY, Sean Keith,PATIL, Namrata Srivastava
申请号：
AU2019225249
公开号：
AU2019225249A1
申请日:
2019.02.26
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The invention provides methods of dosing for the treatment of cancers. In particular, provided are methods for treating human patients having lung cancer, such as non-small cell lung cancer (NSCLC), by administering a combination of an anti-TIGIT antagonist antibody and an anti-PD-L1 antagonist antibody.
